In contrast to these studies of NE-regulated suppression of cancer, ELANE is expressed in promyelocytic leukemia (PML) and sustains PML by inhibiting apoptosis via degradation of BAX a pro-apoptotic protein and upregulation of Bcl-2, an apoptosis inhibitor [61]. Here, PML is linked to acute promyelocytic leukemia.